Proteolytic Enzyme Fortified Protein Supplement in Chronic Pancreatitis.
- Sponsor
- Asian Institute of Gastroenterology, India
- Study ID
- NCT06585735
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Pancreatitis
- Malnutrition
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Proteolytic enzyme fortified protein supplement — DIETARY_SUPPLEMENTGroup I receive Enzotein 15 gms (proteolytic enzyme with 70000 Hb unit tyrosine (HUT) fortified with 15 gms of whey protein), given for 6 weeks. Enzotein will be provided by (Mylin Biotech India Ltd.)
Study Details
A complex disease, Chronic Pancreatitis (CP) is caused by a wide range of factors, including smoking, alcoholism, autoimmune disorders, and obstruction of the major pancreatic duct. In patients who are genetically susceptible to the condition, these factors can result in damage to the acinar, ductal, and islet cells, as well as persistent inflammatory infiltration and fibrosis. Malnutrition is an ongoing concern for persons with CP, even though pain is the primary symptom in most cases. Complications that commonly arise during the disease's natural history include exocrine and endocrine pancreatic insufficiency and local changes (such as pseudocyst, biliary and duodenal blockage, splenic and portal vein thrombosis, and pancreatic cancer). Consequently, CP mortality is higher than that of the general population.
Key Dates
- First listed
- Sep 5, 2024
- Start date
- Sep 1, 2024
- Status verified
- Sep 2024
- Primary completion
- Mar 31, 2025
- Completion
- Jun 30, 2025
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Group AGroup I receive 15 gms of Protein supplements (proteolytic enzyme with 70000 Hb unit tyrosine \[HUT\] fortified with 15 gms of whey protein), given daily for 6 weeks.
- Active Comparator: Group BGroup II will receive equivalent dose of plain protein supplement without proteolytic enzyme, given daily for 6 weeks.
Primary Outcome Measure
Weight gain [ Time Frame: 6 weeks ]
Central Contacts
- Radha Reddy, PhD9849423806
Related Studies
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruiting · Mayo Clinic · Phoenix, Arizona
- Pancreas Registry and High Risk RegistryRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Analysis of Graft Function Following Autologous Islet TransplantationRecruiting · Baylor Research Institute · Dallas, Texas
- QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory TestingRecruiting · Anna Evans Phillips · Baltimore, Maryland